The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Open accessAbstract
A key question in immunology concerns how sterile injury activates innate immunity to mediate damaging inflammation in the absence of foreign invaders. The discovery that HMGB1, a ubiquitous nuclear protein, mediates the activation of innate immune responses led directly to the understanding that HMGB1 plays a critical role at the intersection of the host inflammatory response to sterile and infectious threat. HMGB1 is actively released by stimulation of the innate immune system with exogenous pathogen-derived molecules and is passively released by ischemia or cell injury in the absence of invasion. Established molecular mechanisms of HMGB1 binding and signaling through TLR4 reveal signaling pathways that mediate cytokine release and tissue damage. Experimental strategies that selectively target HMGB1 and TLR4 effectively reverse and prevent activation of innate immunity and significantly attenuate damage in diverse models of sterile and infection-induced threat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The non-histone DNA-binding protein high mobility group protein B1 (HMGB1) is a major pro-inflammatory SASP factor, when externalized from the nucleus into the extracellular environment.39”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Self-citationApetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Park, J. S., Svetkauskaite, D., He, Q., Kim, J., Strassheim, D., Ishizaka, A., & Abraham, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,582
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Self-citationTian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Wang, H., Metz, C., Miller, E. J., et al. (2004) · Nature Medicine · doi:10.1038/nm1124 · Cited by 1,170
Self-citationTracey, K. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2566 · Cited by 1,154
Self-citationThe Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Research works printed but not linked: 2
- Johns EW, 1975, Ciba Found. Symp., 28, 95
- Huttunen HJ, 2002, Cancer Res., 62, 4805
Cited by
Sorted by citations
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,263
PAMP s and DAMP s: signal 0s that spur autophagy and immunity
Tang, D., Kang, R., Coyne, C. B., Zeh, H. J., & Lotze, M. T. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01146.x · Cited by 1,327
The vagus nerve and the inflammatory reflex – linking immunity and metabolism
Pavlov, V. A., & Tracey, K. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.189 · Cited by 1,040
Self-citationSepsis: a roadmap for future research
Cohen, J., Vincent, J., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., Jaton, K., Giulieri, S. G., Delaloye, J., Opal, S. M., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70112-x · Cited by 1,038
Self-citationAutophagy‐based unconventional secretory pathway for extracellular delivery of IL‐1β
Dupont, N., Jiang, S., Pilli, M., Ornatowski, W., Bhattacharya, D., & Deretic, V. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.398 · Cited by 967
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation
Zindel, J., & Kubes, P. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032847 · Cited by 915
NINJ1 mediates plasma membrane rupture during lytic cell death
Kayagaki, N., Kornfeld, O. S., Lee, B. L., Stowe, I. B., O’Rourke, K., Li, Q., Sandoval, W., Yan, D., Kang, J., Xu, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03218-7 · Cited by 857
Chiba, S., Baghdadi, M., Akiba, H., Yoshiyama, H., Kinoshita, I., Dosaka-Akita, H., Fujioka, Y., Ohba, Y., Gorman, J. V., Colgan, J. D., et al. (2012) · Nature Immunology · doi:10.1038/ni.2376 · Cited by 838
Yang, K., Fan, M., Wang, X., Xu, J., Wang, Y., Tu, F., Gill, P. S., Ha, T., Liu, L., Williams, D. L., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00841-9 · Cited by 836
Novel role of PKR in inflammasome activation and HMGB1 release
Lü, B., Nakamura, T., Inouye, K., Li, J., Tang, Y., Lundbäck, P., Valdés‐Ferrer, S. I., Olofsson, P. S., Kalb, T. H., Roth, J., et al. (2012) · Nature · doi:10.1038/nature11290 · Cited by 772
Self-citationSepsis definitions: time for change
Vincent, J., Opal, S. M., Marshall, J. C., & Tracey, K. J. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61815-7 · Cited by 773
Self-citationThe role of oxidative stress during inflammatory processes
Lugrin, J., Rosenblatt‐Velin, N., Parapanov, R., & Liaudet, L. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0241 · Cited by 766
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D. J., Cattaneo, A., De Marchis, F., Liu, J., Antonelli, A., Preti, A., Raeli, L., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120189 · Cited by 720
“Notably, immune cells secrete HMGB1 when activated by infection or tissue damage (Andersson and Tracey, 2011); mesothelioma and other cancer cells secrete HMGB1 constitutively (Jube et al., 2012).”
BackgroundSelf-citationHMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease
Harris, H. E., Andersson, U., & Pisetsky, D. S. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.222 · Cited by 689
Self-citationSepsis: Current Dogma and New Perspectives
Deutschman, C. S., & Tracey, K. J. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.001 · Cited by 708
Self-citationSterile inflammation in the liver
Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666
DAMPs from Cell Death to New Life
Vénéreau, E., Ceriotti, C., & Bianchi, M. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00422 · Cited by 703
Targeting Inflammation Driven by HMGB1
Yang, H., Wang, H., & Andersson, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00484 · Cited by 662
Self-citationCellular degradation systems in ferroptosis
Chen, X., Yu, C., Kang, R., Kroemer, G., & Tang, D. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00728-1 · Cited by 671
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis
Deng, M., Tang, Y., Li, W., Wang, X., Zhang, R., Zhang, X., Zhao, X. S., Liu, J., Tang, C. W., Liu, Z., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.016 · Cited by 596
Self-citationPhysiological roles of hydrogen sulfide in mammalian cells, tissues, and organs
Cirino, G., Szabó, C., & Papapetropoulos, A. (2022) · Physiological Reviews · doi:10.1152/physrev.00028.2021 · Cited by 578
Yang, H., Antoine, D. J., Andersson, U., & Tracey, K. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1212662 · Cited by 542
Self-citationMaugeri, N., Campana, L., Gavina, M., Covino, C., Metrio, M. D., Panciroli, C., Maiuri, L., Maseri, A., D’Angelo, A., Bianchi, M. E., et al. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12710 · Cited by 542
Alarmins: awaiting a clinical response
Chan, J. K.-K., Roth, J., Oppenheim, J. J., Tracey, K. J., Vogl, T., Feldmann, M., Horwood, N. J., & Nanchahal, J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62423 · Cited by 525
Self-citationPKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis
Yang, L., Xie, M., Yang, M., Yu, Y., Zhu, S., Hou, W., Kang, R., Lotze, M. T., Billiar, T. R., Wang, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms5436 · Cited by 509
HMGB1 in Cancer: Good, Bad, or Both?
Kang, R., Zhang, Q., Zeh, H. J., Lotze, M. T., & Tang, D. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0495 · Cited by 505
Romero, R. J., Miranda, J., Chaiworapongsa, T., Korzeniewski, S. J., Chaemsaithong, P., Gotsch, F., Dong, Z., Ahmed, A. I., Yoon, B. H., Hassan, S. S., et al. (2014) · American Journal of Reproductive Immunology · doi:10.1111/aji.12296 · Cited by 495
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
Bertheloot, D., & Latz, E. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.34 · Cited by 455
S100A8/A9: From basic science to clinical application
Pruenster, M., Vogl, T., Roth, J., & Sperandio, M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.015 · Cited by 463
The hallmarks of COVID-19 disease
Tang, D., Comish, P. B., & Kang, R. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008536 · Cited by 467
Negishi, H., Taniguchi, T., & Yanai, H. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028423 · Cited by 467
Accessory molecules for Toll-like receptors and their function
Lee, C. C., Avalos, A. M., & Ploegh, H. L. (2012) · Nature reviews. Immunology · doi:10.1038/nri3151 · Cited by 453
p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes
Davalos, A. R., Kawahara, M., Malhotra, G. K., Schaum, N., Huang, J., Ved, U., Beausejour, C. M., Coppe, J.-P., Rodier, F., & Campisi, J. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201206006 · Cited by 439
Zhang, D., Xu, C., Manwani, D., & Frenette, P. S. (2016) · Blood · doi:10.1182/blood-2015-09-618538 · Cited by 413
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L. W., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 387
MD-2 is required for disulfide HMGB1–dependent TLR4 signaling
Yang, H., Wang, H., Ju, Z., Ragab, A. A. Y., Lundbäck, P., Long, W., Valdés‐Ferrer, S. I., He, M., Pribis, J. P., Li, J., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141318 · Cited by 379
Self-citationPlatelet-derived HMGB1 is a critical mediator of thrombosis
Vogel, S., Bodenstein, R., Chen, Q., Feil, S. C., Feil, R., Rheinlaender, J., Schäffer, T. E., Bohn, E., Frick, J.-S., Borst, O., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81660 · Cited by 368
JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
Lü, B., Antoine, D. J., Kwan, K., Lundbäck, P., Wähämaa, H., Schierbeck, H., Robinson, M., van Zoelen, M. A. D., Yang, H., Li, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316925111 · Cited by 364
Self-citationHigh Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule
Yang, H., Wang, H., Chavan, S. S., & Andersson, U. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00087 · Cited by 366
Self-citationThe Role of HMGB1 in the Pathogenesis of Inflammatory and Autoimmune Diseases
Magna, M., & Pisetsky, D. S. (2014) · Molecular Medicine · doi:10.2119/molmed.2013.00164 · Cited by 358
Tadié, J., Bae, H., Jiang, S., Park, D. W., Bell, C. P., Yang, H., Pittet, J., Tracey, K. J., Thannickal, V. J., Abraham, E. H., et al. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00151.2012 · Cited by 368
Self-citationDAMPs, MAMPs, and NAMPs in plant innate immunity
Choi, H. W., & Klessig, D. F. (2016) · BMC Plant Biology · doi:10.1186/s12870-016-0921-2 · Cited by 378
The proliferation rate paradox in antimitotic chemotherapy
Mitchison, T. J. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-04-0335 · Cited by 354
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
Huebener, P., Pradère, J., Hernandez, C., Gwak, G., Caviglia, J. M., Mu, X., Loike, J. D., Jenkins, R. E., Antoine, D. J., & Schwabe, R. F. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76887 · Cited by 355
Sankowski, R., Mader, S., & Valdés-Ferrer, S. I. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00028 · Cited by 351
Endothelial barrier dysfunction in septic shock
Opal, S. M., & van der Poll, T. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12331 · Cited by 372
Ayeleso, T. B., Matumba, M. G., & Mukwevho, E. (2017) · Molecules · doi:10.3390/molecules22111915 · Cited by 349
Clinical recovery from surgery correlates with single-cell immune signatures
Gaudilliere, B. L., Fragiadakis, G. K., Bruggner, R. V., Nicolau, M., Finck, R., Tingle, M. S., Silva, J., Ganio, E. A., Yeh, C. G., Maloney, W. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009701 · Cited by 339
Danger signals in stroke and their role on microglia activation after ischemia
Gülke, E., Gelderblom, M., & Magnus, T. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418774254 · Cited by 321
Immunogenic effects of chemotherapy-induced tumor cell death
Wang, Y., Fletcher, R., Yu, J., & Zhang, L. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.003 · Cited by 328
Regulation of alveolar macrophage death in acute lung inflammation
Fan, E., & Fan, J. (2018) · Respiratory Research · doi:10.1186/s12931-018-0756-5 · Cited by 320
High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells
Andersson, U., Yang, H., & Harris, H. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.011 · Cited by 309
Self-citationRole of nonresolving inflammation in hepatocellular carcinoma development and progression
Yu, L., Yan, L., & Wang, H. (2018) · npj Precision Oncology · doi:10.1038/s41698-018-0048-z · Cited by 309
The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
Huebener, P., Pradère, J., Hernandez, C., Gwak, G., Caviglia, J. M., Mu, X., Loike, J. D., Jenkins, R. E., Antoine, D. J., & Schwabe, R. F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126975 · Cited by 301
Crews, F. T., Qin, L., Sheedy, D. L., Vetreno, R. P., & Zou, J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.030 · Cited by 305
Many faces of DAMPs in cancer therapy
Krysko, O., Aaes, T. L., Bachert, C., Vandenabeele, P., & Krysko, D. V. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.156 · Cited by 309
HMGB1 in Inflammation and Cancer
Wang, S., & Zhang, Y. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00950-x · Cited by 294
Hydrogen sulfide: An endogenous regulator of the immune system
Dilek, N., Papapetropoulos, A., Toliver-Kinsky, T. E., & Szabó, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105119 · Cited by 297
Extracellular HMGB1 as a therapeutic target in inflammatory diseases
Andersson, U., Yang, H., & Harris, H. E. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1439924 · Cited by 291
Self-citationInflammatory and Immune Responses to Surgery and Their Clinical Impact
Alazawi, W., Pirmadjid, N., Lahiri, R. P., & Bhattacharya, S. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001691 · Cited by 282
Systemic inflammation after stroke: implications for post‐stroke comorbidities
Simats, A., & Liesz, A. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216269 · Cited by 276
HMGB1 Promotes Drug Resistance in Osteosarcoma
Huang, J. X., Ni, J., Liu, K., Yu, Y. H., Xie, M., Kang, R., Vernon, P. J., Cao, L., & Tang, D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2001 · Cited by 279
Sterile inflammation and pregnancy complications: a review
Nadeau‐Vallée, M., Obari, D., Palacios, J. L., Brien, M., Duval, C., Chemtob, S., & Girard, S. (2016) · Reproduction · doi:10.1530/rep-16-0453 · Cited by 277
Oxidative stress-mediated HMGB1 biology
Yan, Y. Q., Tang, D., & Kang, R. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00093 · Cited by 268
Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats
Zhu, L., Gu, P., & Shen, H. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.036 · Cited by 253
HMGB1 as biomarker and drug target
Vénéreau, E., Leo, F. D., Mezzapelle, R., Careccia, G., Musco, G., & Bianchi, M. E. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.031 · Cited by 245
Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis
Xu, J., Jiang, Y., Wang, J., Shi, X., Liu, Q., Liu, Z., Li, Y., Scott, M. J., Xiao, G., Li, S., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.40 · Cited by 239
Heatstroke induces liver injury via IL-1β and HMGB1-induced pyroptosis
Geng, Y., Ma, Q., Liu, Y., Peng, N., Yuan, F., Li, X.-G., Li, M., Wu, Y., Li, B.-L., Song, W.-B., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.010 · Cited by 241
Anti–high mobility group box‐1 antibody therapy for traumatic brain injury
Okuma, Y., Liu, K., Wake, H., Zhang, J., Maruo, T., Date, I., Yoshino, T., Ohtsuka, A., Otani, N., Tomura, S., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23602 · Cited by 236
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 236
Kang, R., Tang, D., Schapiro, N. E., Loux, T., Livesey, K. M., Billiar, T. R., Wang, H., Houten, B. V., Lotze, M. T., & Zeh, H. J. (2013) · Oncogene · doi:10.1038/onc.2012.631 · Cited by 233
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Andersson, J., Ottestad, W., & Tracey, K. J. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00172-4 · Cited by 232
Self-citationIndirect regulation of HMGB1 release by gasdermin D
Volchuk, A., Ye, A. A., Chi, L., Steinberg, B. E., & Goldenberg, N. M. (2020) · Nature Communications · doi:10.1038/s41467-020-18443-3 · Cited by 232
Severe COVID-19: NLRP3 Inflammasome Dysregulated
van den Berg, D. F., & Velde, A. A. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01580 · Cited by 227
Delayed kidney graft function: from mechanism to translation
Schröppel, B., & Legendre, C. M. (2014) · Kidney International · doi:10.1038/ki.2014.18 · Cited by 224
The origin and properties of extracellular DNA: From PAMP to DAMP
Pisetsky, D. S. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.04.006 · Cited by 231
Innate and adaptive immune responses to cell death
Rock, K. L., Lai, J., & Kono, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01040.x · Cited by 226
Zhang, P., Yang, M., Chen, C., Liu, L., Wei, X., & Zeng, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01455 · Cited by 219
Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis
Maugeri, N., Capobianco, A., Rovere, P. Q., Ramirez, G. A., Tombetti, E., Valle, P. D., Monno, A., D’Alberti, V., Gasparri, A. M., Franchini, S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao3089 · Cited by 215
HMGB1 and leukocyte migration during trauma and sterile inflammation
Vénéreau, E., Schiraldi, M., Uguccioni, M., & Bianchi, M. E. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.10.037 · Cited by 217
Chronic Inflammation as a Link between Periodontitis and Carcinogenesis
Hoare, A., Soto, C., Rojas-Celis, V., & Bravo, D. (2019) · Mediators of Inflammation · doi:10.1155/2019/1029857 · Cited by 219
Intracellular Hmgb1 Inhibits Inflammatory Nucleosome Release and Limits Acute Pancreatitis in Mice
Kang, R., Zhang, Q., Hou, W., Yan, Z., Chen, R., Bonaroti, J. W., Bansal, P., Billiar, T. R., Tsung, A., Wang, Q., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.12.015 · Cited by 213
Self-citationLü, B., Kwan, K., Levine, Y. A., Olofsson, P. S., Yang, H., Li, J., Joshi, S., Wang, H., Andersson, U., Chavan, S. S., et al. (2014) · Molecular Medicine · doi:10.2119/molmed.2013.00117 · Cited by 209
Self-citationNAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation
Audrito, V., Messana, V. G., & Deaglio, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00358 · Cited by 215
Redox Regulation of Inflammation: Old Elements, a New Story
Lei, Y., Wang, K., Deng, L., Chen, Y., Nice, E. C., & Huang, C. (2014) · Medicinal Research Reviews · doi:10.1002/med.21330 · Cited by 210
Platelets in tissue repair: control of apoptosis and interactions with regenerative cells
Gawaz, M., & Vogel, S. (2013) · Blood · doi:10.1182/blood-2013-05-468694 · Cited by 217
The high mobility group box: the ultimate utility player of a cell
Malarkey, C. S., & Churchill, M. E. A. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.09.003 · Cited by 207
Hu, Y., He, Z., Li, Z., Wang, Y., Wu, N., Sun, H., Zhou, Z., Hu, Q., & Cong, X. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01682-2 · Cited by 206
Chi, W., Chen, H., Li, F., Zhu, Y., Yin, W. H., & Zhuo, Y. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0360-2 · Cited by 205
Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation
Zhu, X., Messer, J. S., Wang, Y., Lin, F., Cham, C. M., Chang, J. J., Billiar, T. R., Lotze, M. T., Boone, D. L., & Chang, E. B. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76344 · Cited by 208
AGEs, RAGEs and s-RAGE; friend or foe for cancer
Ahmad, S., Khan, H., Siddiqui, Z., Khan, M. Y., Rehman, S., Shahab, U., Godovikova, T. S., Silnikov, V. N., & Moinuddin, M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.001 · Cited by 196
Downey, C. M., Aghaei, M., Schwendener, R. A., & Jirik, F. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099988 · Cited by 197
He, H., Wang, Y., Le, Y., Duan, K., Yan, X., Liao, Q., Liao, Y., Tong, J., Terrando, N., & Ouyang, W. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12018 · Cited by 194
Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury
Kayagaki, N., Stowe, I. B., Alegre, K. O., Deshpande, I., Wu, S., Lin, Z., Kornfeld, O. S., Lee, B. L., Zhang, J., Liu, J., et al. (2023) · Nature · doi:10.1038/s41586-023-06191-5 · Cited by 195
Key Role of DAMP in Inflammation, Cancer, and Tissue Repair
Pandolfi, F., Altamura, S., Frosali, S., & Conti, P. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.02.028 · Cited by 198
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
Stojanović, S. D., Fiedler, J., Bauersachs, J., Thum, T., & Sedding, D. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz919 · Cited by 188
High‐mobility group box‐1 in sterile inflammation
Tsung, A., Tohme, S., & Billiar, T. R. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12276 · Cited by 187
Metadata
- Authors
- Andersson, U., & Tracey, K. J.
- Affiliations
- Karolinska University Hospital (SE)
- Feinstein Institute for Medical Research (US)
- ORCID
- Tracey, Kevin J.
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2011-04-23
- Volume
- 29
- Issue
- 1
- Pages
- 139-162
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- PMC
- PMC4536551
- OpenAlex
- W2114445825
- Cited by
- 1,437
- References
- 148
- Citations by year
- 2026: 76 · 2025: 70 · 2024: 74 · 2023: 69 · 2022: 100 · 2021: 126 · 2020: 94 · 2019: 95 · 2018: 105 · 2017: 89 · 2016: 106 · 2015: 100 · 2014: 131 · 2013: 94 · 2012: 76
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM062508)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- HMGB1, sterile inflammation, infection, innate immunity, TLR4, HMGB1 release, HMGB1 signaling, cytokine production, tissue damage, ischemia, cell damage
- MeSH terms
- Animals, Humans, Immunity, Innate, Infections, Inflammation, Drug Delivery Systems, HMGB1 Protein, Toll-Like Receptor 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
